160 related articles for article (PubMed ID: 36941500)
1. Impact of cisplatin-induced acute kidney injury on long-term renal function in patients with solid tumors.
Hino A; Muto S; Shimada Y; Hori S; Isotani S; Nagata M; Horie S
Clin Exp Nephrol; 2023 Jun; 27(6):506-518. PubMed ID: 36941500
[TBL] [Abstract][Full Text] [Related]
2. Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study.
Bhat ZY; Cadnapaphornchai P; Ginsburg K; Sivagnanam M; Chopra S; Treadway CK; Lin HS; Yoo G; Sukari A; Doshi MD
PLoS One; 2015; 10(11):e0142225. PubMed ID: 26556481
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin.
van der Vorst MJDL; Neefjes ECW; Toffoli EC; Oosterling-Jansen JEW; Vergeer MR; Leemans CR; Kooistra MP; Voortman J; Verheul HMW
BMC Cancer; 2019 Nov; 19(1):1066. PubMed ID: 31703649
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Renal Outcomes after Cisplatin Treatment.
Latcha S; Jaimes EA; Patil S; Glezerman IG; Mehta S; Flombaum CD
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1173-1179. PubMed ID: 27073199
[TBL] [Abstract][Full Text] [Related]
5. KDIGO (Kidney Disease: Improving Global Outcomes) criteria could be a useful outcome predictor of cisplatin-induced acute kidney injury.
Mizuno T; Sato W; Ishikawa K; Shinjo H; Miyagawa Y; Noda Y; Imai E; Yamada K
Oncology; 2012; 82(6):354-9. PubMed ID: 22722365
[TBL] [Abstract][Full Text] [Related]
6. Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients.
Ishitsuka R; Miyazaki J; Ichioka D; Inoue T; Kageyama S; Sugimoto M; Mitsuzuka K; Matsui Y; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Kawai K; Nishiyama H
Clin Exp Nephrol; 2017 Aug; 21(4):732-740. PubMed ID: 27565169
[TBL] [Abstract][Full Text] [Related]
7. Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study.
McMahon KR; Harel-Sterling M; Pizzi M; Huynh L; Hessey E; Zappitelli M
Pediatr Nephrol; 2018 Dec; 33(12):2311-2320. PubMed ID: 30218190
[TBL] [Abstract][Full Text] [Related]
8. The risk factors of severe acute kidney injury induced by cisplatin.
Mizuno T; Ishikawa K; Sato W; Koike T; Kushida M; Miyagawa Y; Yamada K; Hirata S; Imai E; Noda Y
Oncology; 2013; 85(6):364-9. PubMed ID: 24335484
[TBL] [Abstract][Full Text] [Related]
9. The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study.
Ueno S; Murashima M; Ogawa R; Saito M; Ito S; Hayakawa S; Okubo T; Sagawa H; Tanaka T; Takahashi H; Matsuo Y; Mitsui A; Kimura M; Hamano T; Takiguchi S
BMC Surg; 2023 Mar; 23(1):67. PubMed ID: 36973771
[TBL] [Abstract][Full Text] [Related]
10. Risk and impact of delayed renal impairment in patients with locally advanced head and neck squamous cell carcinoma receiving chemoradiotherapy with cisplatin.
Patimarattananan T; Nongnuch A; Pattaranutaporn P; Unwanatham N; Jiarpinitnun C; Ngamphaiboon N
Support Care Cancer; 2021 Feb; 29(2):877-887. PubMed ID: 32524284
[TBL] [Abstract][Full Text] [Related]
11. The effect of rapid infusion of cisplatin on nephrotoxicity in patients with lung carcinoma.
Mense ES; Smit AAJ; Crul M; Franssen EJF
J Clin Pharm Ther; 2019 Apr; 44(2):249-257. PubMed ID: 30578577
[TBL] [Abstract][Full Text] [Related]
12. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
Knijnenburg SL; Mulder RL; Schouten-Van Meeteren AY; Bökenkamp A; Blufpand H; van Dulmen-den Broeder E; Veening MA; Kremer LC; Jaspers MW
Cochrane Database Syst Rev; 2013 Oct; (10):CD008944. PubMed ID: 24101439
[TBL] [Abstract][Full Text] [Related]
13. Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study.
McMahon KR; Rod Rassekh S; Schultz KR; Pinsk M; Blydt-Hansen T; Mammen C; Tsuyuki RT; Devarajan P; Cuvelier GD; Mitchell LG; Baruchel S; Palijan A; Carleton BC; Ross CJ; Zappitelli M;
Can J Kidney Health Dis; 2017; 4():2054358117690338. PubMed ID: 28270931
[TBL] [Abstract][Full Text] [Related]
14. Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study.
Shoji S; Hosojima M; Kabasawa H; Kondo R; Miura S; Watanabe S; Aoki N; Kaseda R; Kuwahara S; Tanabe N; Hirayama Y; Narita I; Kikuchi T; Kagamu H; Saito A
BMC Cancer; 2019 Dec; 19(1):1170. PubMed ID: 31791266
[TBL] [Abstract][Full Text] [Related]
15. Acute kidney injury during cisplatin therapy and associations with kidney outcomes 2 to 6 months post-cisplatin in children: a multi-centre, prospective observational study.
McMahon KR; Lebel A; Rassekh SR; Schultz KR; Blydt-Hansen TD; Cuvelier GDE; Mammen C; Pinsk M; Carleton BC; Tsuyuki RT; Ross CJD; Huynh L; Yordanova M; Crépeau-Hubert F; Wang S; Palijan A; Lee J; Boyko D; Zappitelli M;
Pediatr Nephrol; 2023 May; 38(5):1667-1685. PubMed ID: 36260162
[TBL] [Abstract][Full Text] [Related]
16. A Nomogram to Predict Significant Estimated Glomerular Filtration Rate Reduction After Robotic Partial Nephrectomy.
Martini A; Cumarasamy S; Beksac AT; Abaza R; Eun DD; Bhandari A; Hemal AK; Porter JR; Badani KK
Eur Urol; 2018 Dec; 74(6):833-839. PubMed ID: 30224195
[TBL] [Abstract][Full Text] [Related]
17. Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.
Sato K; Watanabe S; Ohtsubo A; Shoji S; Ishikawa D; Tanaka T; Nozaki K; Kondo R; Okajima M; Miura S; Tanaka J; Sakagami T; Koya T; Kagamu H; Yoshizawa H; Narita I
BMC Cancer; 2016 Mar; 16():222. PubMed ID: 26979596
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin.
Chang C; Hu Y; Hogan SL; Mercke N; Gomez M; O'Bryant C; Bowles DW; George B; Wen X; Aleksunes LM; Joy MS
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640195
[TBL] [Abstract][Full Text] [Related]
19. Comparison of methods for estimating glomerular filtration rate in head and neck cancer patients treated with cisplatin.
Lindberg L; Brødbæk K; Hägerström EG; Bentzen J; Kristensen B; Zerahn B
Scand J Clin Lab Invest; 2017 Jul; 77(4):237-246. PubMed ID: 28317454
[TBL] [Abstract][Full Text] [Related]
20. Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
Suer E; Mermerkaya M; Gülpınar Ö; Afandiyev F; Baltacı S; Türkölmez K; Bedük Y
J Urol; 2013 Dec; 190(6):2081-5. PubMed ID: 23764076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
